Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Spreadsheets
3 Hurdles to Moving on From Excel
Staffers often resist pivoting away from the popular spreadsheet platform.
By
Bob Violino
| May 25, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Jacob Van Naarden
M&A
Eli Lilly to Buy Cancer Drug Specialists Loxo Oncology
In the second major pharmaceutical deal of the year, Eli Lilly will pay about $8 billion for Loxo Oncology.
By
William Sprouse
| January 7, 2019
Read More
